Oaktree Fund Advisors’s Alvotech ALVO Stock Holding History

Oaktree Fund Advisors’s Portfolio ALVO Stock Details ALVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Sell	76,023 -141,640	-65%	-$506K	0.49%	13
2026 Q1	$264K	Buy	217,663 +70,820	+48%	+$311K	0.46%	12
2025 Q4	$397K	Buy	146,843 +70,820	+93%	+$447K	0.73%	13
2025 Q3	$623K	Hold	76,023	–	–	1.15%	14
2025 Q2	$693K	Sell	76,023 -29,093	-28%	-$273K	1.2%	15
2025 Q1	$1.02M	Sell	105,116 -11,178	-10%	-$136K	1.48%	20
2024 Q4	$1.54M	Sell	116,294 -2,450	-2%	-$30.2K	2.58%	15
2024 Q3	$1.41M	Hold	118,744	–	–	1.59%	20
2024 Q2	$1.44M	Sell	118,744 -17,307	-13%	-$231K	1.36%	16
2024 Q1	$1.66M	Sell	136,051 -387,864	-74%	-$5.68M	1.49%	16
2023 Q4	$6.01M	Buy	523,915 +52,662	+11%	+$497K	5.4%	10
2023 Q3	$4.3M	Sell	471,253 -352,944	-43%	-$3.27M	4.31%	11
2023 Q2	$6.38M	Sell	824,197 -260,720	-24%	-$2.43M	5.41%	7
2023 Q1	$14M	Buy	1,084,917 +417,550	+63%	+$5.34M	13.22%	1
2022 Q4	$6.67M	Hold	667,367	–	–	9.97%	4
2022 Q3	$4.51M	Hold	667,367	–	–	7.02%	7
2022 Q2	$5.48M	Buy	+667,367	New	+$6.21M	9.61%	5

Other funds holding ALVO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Littlejohn & Co Greenwich, Connecticut $78.6M AUM 1.93% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Oaktree Fund Advisors's ALVO Position: Q2 2026 in Review

Oaktree Fund Advisors reduced its Alvotech (ALVO) stake by 65% in Q2 2026, selling an estimated $506K and leaving 76,023 shares worth $281K. The position accounts for 0.49% of the portfolio, ranked #13.

Oaktree Fund Advisors first reported a position in ALVO in Q2 2022 and has held it in 17 quarters since. The position peaked at $14M in Q1 2023. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

Oaktree Fund Advisors held 76,023 shares of Alvotech worth $281K as of Q2 2026.
Oaktree Fund Advisors sold 141,640 Alvotech shares in Q2 2026, an estimated $506K.
Alvotech made up 0.49% of Oaktree Fund Advisors's portfolio in Q2 2026, its #13 holding.
Oaktree Fund Advisors first reported a position in Alvotech in Q2 2022 and has held it in 17 quarters since.
Oaktree Fund Advisors's Alvotech position peaked at $14M in Q1 2023.
72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Oaktree Fund Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.